A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1998
10/27/1998	US5827863 Pyrazole derivatives as angiotensin II antagonists
10/27/1998	US5827862 Carbostyril or benzazepine derivatives
10/27/1998	US5827859 HIV protease inhibitors
10/27/1998	US5827858 Administered to treat aids
10/27/1998	US5827857 Pyrido-fused thienyl- and furanyl-oxazolidinones
10/27/1998	US5827856 Method of treating insulin resistance
10/27/1998	US5827855 Anticholesterol agents treating cardiovascular disorders; enzyme inhibitors
10/27/1998	US5827850 1,2,4-benzotriazine oxides formulations
10/27/1998	US5827849 Cyclic dericatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/27/1998	US5827847 Treatment of cognitive disorders with piperazine derivatives
10/27/1998	US5827846 Carbazole derivatives as agents against multi-drug resistance
10/27/1998	US5827844 Having an n-pyrrolidinyl or n-piperidinyl group
10/27/1998	US5827843 Oral dosing with a constant dose of progesterone and a variable one of the estrogen to avoid blood loss
10/27/1998	US5827842 14α, 17α-C2 -bridged norprogesterone derivatives
10/27/1998	US5827841 Method for enhancement of production of lymphokines and applications thereof
10/27/1998	US5827840 Promotion of wound healing by chemically-modified tetracyclines
10/27/1998	US5827838 Method for the treatment of diseases related with protein isoprenylation
10/27/1998	US5827837 Blocking selectin binding by administering substituted inositols(hexakis-phosphates or sulfates); treating asthma,arthritis, septic shock, respiratory, vascular and autoimmune disorders, malignancies, infections
10/27/1998	US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
10/27/1998	US5827833 Triciribine and analogs as antiviral drugs
10/27/1998	US5827832 Method of protecting brain tissue from cerebral infarction subsequent to ischemia
10/27/1998	US5827831 Lipid nucleotide analog prodrugs for oral administration
10/27/1998	US5827828 Sulfated glycolipids and antibodies thereto for prophylaxis or therapy of diabetes
10/27/1998	US5827819 Pharmaceutical composition comprising a psychotropic, neurotropic or neurological drug, a polar lipid carrier, two linker functional groups and a spacer; facilitates entry of drugs into cells and tissues
10/27/1998	US5827740 A mixture of glucocorticoids and an adenosine monophosphates inducing the fat cells by cell differentiation
10/27/1998	US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells
10/27/1998	US5827703 Methods and composition for in vivo gene therapy
10/27/1998	US5827652 Stereoisomers; treatment of macular degeneration
10/27/1998	US5827644 Adding thiazine dye to biological fluid, then exposure to light yields 8-hydroxyguanosine which is cytotoxic to human immunodeficiency virus
10/27/1998	US5827543 Methods and compositions for the prevention and treatment of urogenital disorders
10/27/1998	US5827536 Anticholesterol drug solution comprising a solubilizer nonionic surfactant diethylene glycol monoethyl ether
10/27/1998	US5827529 External preparation for application to the skin containing lidocaine
10/27/1998	US5827526 Administering the fructooligosaccharides, nystose and 1f-beta-fructofuranosyl nystose; infants
10/27/1998	US5827525 Buccal delivery system for therapeutic agents
10/27/1998	US5827520 Vehicle and composition containing this vehicle and a stabilized cosmetic or dermatological active substance
10/27/1998	US5827512 Method for the treatment of bronchial asthma and like hypersensitivity diseases by administration of anionic polymers
10/27/1998	US5827245 Using crystals and a gas-tight, sealed packing with dehydrating water-absorbing substance, storage stability; increased diffusion
10/27/1998	CA2154870C Silylated acetylcholinesterase inhibitors
10/27/1998	CA2102179C Quinuclidine derivatives
10/27/1998	CA2078694C Hepatitis b vaccine
10/27/1998	CA2039869C Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
10/27/1998	CA1340104C 23-deoxy derivatives of ll-f28249 compounds
10/27/1998	CA1340100C Polynucleotide commposition and method
10/25/1998	CA2207753A1 Modulators of multi-drug resistances
10/23/1998	CA2235438A1 Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
10/22/1998	WO1998046765A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998	WO1998046764A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
10/22/1998	WO1998046763A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998	WO1998046751A1 Osteoprotegerin binding proteins and receptors
10/22/1998	WO1998046648A1 Interactive system for substance presentation and elimination
10/22/1998	WO1998046643A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
10/22/1998	WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998	WO1998046638A1 A novel th2-specific gene
10/22/1998	WO1998046619A1 Glycine transporter
10/22/1998	WO1998046618A1 Morphine derivatives
10/22/1998	WO1998046611A1 Compounds
10/22/1998	WO1998046610A1 Process for preparing single enantiomer narwedine
10/22/1998	WO1998046609A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
10/22/1998	WO1998046606A1 Novel compounds
10/22/1998	WO1998046605A1 5,7-disubstituted 4-aminopyrido[2,3-d]pyrimidine compounds and their use as adenosine kinase inhibitors
10/22/1998	WO1998046604A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998	WO1998046603A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998	WO1998046602A1 Alkaloid halide salts of swainsonine and methods of use
10/22/1998	WO1998046598A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods
10/22/1998	WO1998046596A1 Method for providing neuro-protective effects
10/22/1998	WO1998046595A1 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists
10/22/1998	WO1998046591A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998	WO1998046590A1 Thermogenic composition and benzazepine thermogenics
10/22/1998	WO1998046589A2 Indazole amide compounds as serotoninergic agents
10/22/1998	WO1998046588A2 Compounds and therapies for the prevention of vascular and non-vascular pathologies
10/22/1998	WO1998046586A1 A new process
10/22/1998	WO1998046585A1 Inhibitors of cholesterol esterase
10/22/1998	WO1998046582A1 Protease inhibitors
10/22/1998	WO1998046576A2 Halo-alkoxycarbonyl prodrugs
10/22/1998	WO1998046575A1 Crambescidin compounds
10/22/1998	WO1998046574A1 Pyridazine and phthalazine derivatives, process of their preparation and their use as anticonvulsants
10/22/1998	WO1998046572A1 Imidazole and imidazoline derivatives and uses thereof
10/22/1998	WO1998046570A1 Substituted heteroaromatic 5-ht1f agonists
10/22/1998	WO1998046563A1 Metalloproteinase inhibitors
10/22/1998	WO1998046268A1 Medicinal composition
10/22/1998	WO1998046266A1 Compositions containing an angiotensin ii antagonist and an angiotensin ii agonist for use in the treatment of erectile dysfunction
10/22/1998	WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998	WO1998046245A1 Method and composition for treating sleep apnea
10/22/1998	WO1998046244A1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine
10/22/1998	WO1998046243A2 Pharmaceutical compositions having appetite suppressant activity
10/22/1998	WO1998046241A1 A combination therapy for hiv infections
10/22/1998	WO1998046239A1 Extended release formulations of erythromycin derivatives
10/22/1998	WO1998046238A1 Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
10/22/1998	WO1998046237A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998	WO1998046236A1 Method of inhibiting bone resorption
10/22/1998	WO1998046235A1 Analgesic combination
10/22/1998	WO1998046233A1 Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s
10/22/1998	WO1998046230A1 Method for treating cerebral focal stroke
10/22/1998	WO1998046228A1 Retinoid antagonists and uses thereof
10/22/1998	WO1998046227A1 Composition for treating pain
10/22/1998	WO1998046226A1 Method for treating schizophrenia
10/22/1998	WO1998046225A1 Method for treating schizophrenia
10/22/1998	WO1998046224A1 Compositions and method for treating bladder dysfunction
10/22/1998	WO1998046223A1 Retinoid antagonists for prevention of surgical adhesions
10/22/1998	WO1998046222A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment

1 ... 6590 6591 6592 6593 6594 6595 6596 6597 6598 6599 6600 6601 6602 6603 6604 6605 6606 6607 6608 6609 6610 ... 7860